Pyxis Oncology Inc. (PYXS) PT Lowered to $5 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev lowered the price target on Pyxis Oncology Inc. (NASDAQ: PYXS) to $5.00 (from $8.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
